Academic literature on the topic 'Antibacterial agents'

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the lists of relevant articles, books, theses, conference reports, and other scholarly sources on the topic 'Antibacterial agents.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Journal articles on the topic "Antibacterial agents"

1

Bremner, John B. "Some approaches to new antibacterial agents." Pure and Applied Chemistry 79, no. 12 (2007): 2143–53. http://dx.doi.org/10.1351/pac200779122143.

Full text
Abstract:
Bacteria use a number of resistance mechanisms to counter the antibacterial challenge, and one of these is the expression of transmembrane protein-based efflux pumps which can pump out antibacterials from within the cells, thus lowering the antibacterial concentration to nonlethal levels. For example, in S. aureus, the NorA pump can pump out the antibacterial alkaloid berberine and ciprofloxacin. One general strategy to reduce the health threat of resistant bacteria is to block a major bacterial resistance mechanism at the same time as interfering with another bacterial pathway or target site.
APA, Harvard, Vancouver, ISO, and other styles
2

Kaye, Elaine T., and Kenneth M. Kaye. "TOPICAL ANTIBACTERIAL AGENTS." Infectious Disease Clinics of North America 9, no. 3 (1995): 547–59. http://dx.doi.org/10.1016/s0891-5520(20)30685-1.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Thorsteinsson, T., T. Loftsson, and M. Masson. "Soft Antibacterial Agents." Current Medicinal Chemistry 10, no. 13 (2003): 1129–36. http://dx.doi.org/10.2174/0929867033457520.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Brickner, Steven J. "Oxazolidinone Antibacterial Agents." Current Pharmaceutical Design 2, no. 2 (1996): 175–94. http://dx.doi.org/10.2174/1381612802666220921173820.

Full text
Abstract:
The oxazolidinones are a new class of synthetic antibacterial agents. These compounds demonstrate potent in vitro and in vivo activity against important human pathogens, including multiple antibiotic-resistant strains of gram positive organisms including the staphylococci, streptococci, and enterococci. The oxazolidinones have a novel mechanism of action, inhibiting bacterial protein synthesis at a very early step prior to initiation. Literature disclosures have described the inability to detect in vitro bacterial resistance development to the oxazolidinones. Only the (S)-enantiomer is active;
APA, Harvard, Vancouver, ISO, and other styles
5

Telford, Mark. "Releasing antibacterial agents." Materials Today 7, no. 12 (2004): 10. http://dx.doi.org/10.1016/s1369-7021(04)00613-3.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Hussar, Daniel A. "New Antibacterial Agents." American Pharmacy 33, no. 1 (1993): 41–46. http://dx.doi.org/10.1016/s0160-3450(15)30889-8.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Kaye, Elaine T. "TOPICAL ANTIBACTERIAL AGENTS." Infectious Disease Clinics of North America 14, no. 2 (2000): 321–39. http://dx.doi.org/10.1016/s0891-5520(05)70250-6.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Lio, Peter A., and Elaine T. Kaye. "Topical Antibacterial Agents." Medical Clinics of North America 95, no. 4 (2011): 703–21. http://dx.doi.org/10.1016/j.mcna.2011.03.008.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Lio, Peter A., and Elaine T. Kaye. "Topical antibacterial agents." Infectious Disease Clinics of North America 18, no. 3 (2004): 717–33. http://dx.doi.org/10.1016/j.idc.2004.04.008.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Lio, Peter A., and Elaine T. Kaye. "Topical Antibacterial Agents." Infectious Disease Clinics of North America 23, no. 4 (2009): 945–63. http://dx.doi.org/10.1016/j.idc.2009.06.006.

Full text
APA, Harvard, Vancouver, ISO, and other styles
More sources

Dissertations / Theses on the topic "Antibacterial agents"

1

Zhang, Huichun. "Metal oxide-facilitated oxidation of antibacterial agents." Diss., Available online, Georgia Institute of Technology, 2004:, 2004. http://etd.gatech.edu/theses/available/etd-07072004-152317/unrestricted/zhang%5Fhuichun%5F200407%5Fphd.pdf.

Full text
Abstract:
Thesis (Ph. D.)--School of Civil and Environmental Engineering, Georgia Institute of Technology, 2005. Directed by Ching-Hua Huang.<br>Wine, Paul, Committee Member ; Pavlostathis, Spyros, Committee Member ; Mulholland, James, Committee Member ; Yiacoumi, Sotira, Committee Member ; Huang, Ching-Hua, Committee Chair. Includes bibliographical references.
APA, Harvard, Vancouver, ISO, and other styles
2

Tan, Jinlong. "Design and Synthesis of Novel Antibacterial Agents." Thesis, The University of Sydney, 2021. https://hdl.handle.net/2123/25809.

Full text
Abstract:
The latest data on antimicrobial resistance (AMR) related mortality is alarming. A conservative estimate places current global death due to AMR infections at 700,000 annually and projections anticipate that this could rise to 10 million by 2050. Over 50 major initiatives have emerged from the European Union (EU), United Kingdom (UK) and the United States of America (US) since 2007 aimed at improving surveillance, stewardship, and refreshing the drug development pipeline. The identification of priority pathogens, such as the ESKAPE (Enterococcus faecium, Staphylococcus aureus, Klebsiella pneumo
APA, Harvard, Vancouver, ISO, and other styles
3

Marshall, Neil J. "Antibacterial agents designed to exploit peptide transport systems." Thesis, Bangor University, 1994. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.262012.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Penishkevich, Ya. "Ophthalmic topical antibacterial agents: current and evolving options." Thesis, БДМУ, 2020. http://dspace.bsmu.edu.ua:8080/xmlui/handle/123456789/18146.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Smith, Nichola Ann. "Photoactivatable Ru(II) polypyridyl complexes as antibacterial agents." Thesis, University of Warwick, 2015. http://wrap.warwick.ac.uk/76173/.

Full text
Abstract:
Novel photoactive ruthenium(II) complexes were designed to incorporate existing anti-tuberculosis drugs, isoniazid and nicotinamide, that could be released from the ruthenium(II) cage by photoactivation with visible light. Two sets of complexes were synthesised based on cis-[Ru(N-N')2(L)2][PF6]2and cis-[Ru(N-N')2(L)X][PF6], where N-N' is 2,2'-bipyridine (bpy) or 1,10-phenanthroline (phen), L is isoniazid (INH) or nicotinamide (NA) and X is either Cl or I. Their dynamic behaviour in solution was explored using NMR to probe the presence of atropisomers. In the case of cis-[Ru(bpy)2(NA)Cl][PF6] (
APA, Harvard, Vancouver, ISO, and other styles
6

Nielsen, Elisabet I. "Pharmacometric Models for Antibacterial Agents to Improve Dosing Strategies." Doctoral thesis, Uppsala universitet, Institutionen för farmaceutisk biovetenskap, 2011. http://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-144909.

Full text
Abstract:
Antibiotics are among the most commonly prescribed drugs. Although the majority of these drugs were developed several decades ago, optimal dosage (dose, dosing interval and treatment duration) have still not been well defined. This thesis focuses on the development and evaluation of pharmacometric models that can be used as tools in the establishment of improved dosing strategies for novel and already clinically available antibacterial drugs. Infectious diseases are common causes of death in preterm and term newborn infants. A population pharmacokinetic (PK) model for gentamicin was developed
APA, Harvard, Vancouver, ISO, and other styles
7

Das, Sanjan Kumar. "Application of Structural Genomics for Developing Novel Antibacterial Agents." Thesis, University of Sheffield, 2007. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.486462.

Full text
Abstract:
The structure-based design of novel antibiotics has great potentiaL To achieve this goal the first step is to gather structural information on relevant proteins and utilise this to find inhibitors through a process of screening and subsequent optimising using structural data. In this· pilot study a number of essential gene products from Bacillus subtilis were targeted for structural studies where homologues were present in pathogenic microorganisms. In the initial analysis 41 essential genes of unknown structure or function were selected for structure determination. From this list 9 genes w
APA, Harvard, Vancouver, ISO, and other styles
8

Griffiths, Jennifer Mary. "Model systems to investigate bacterial persistence to antibacterial agents." Thesis, University of Leeds, 2012. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.590484.

Full text
Abstract:
Bacterial persistence describes the phenotypic variation displayed by clonal bacterial populations which permits a small fraction of cells to survive exposure to antimicrobials. The phenomenon was first described in the 19405 by Joseph Bigger who observed that penicillin could not sterilize a culture of Staphylococcus aureus. The surviving cells were not resistant mutants as they displayed equal susceptibility to penicillin as the parent population upon subculture. Among the various hypotheses which have been proposed to explain this phenomenon, the majority consider persisters to be dormant T
APA, Harvard, Vancouver, ISO, and other styles
9

Carraco, Moreira Joao Bruno. "Characterisation of symmetric bis-benzimidazoles as antibacterial chemotherapeutic agents." Thesis, University of London, 2012. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.579712.

Full text
Abstract:
Nosocomial and community-acquired infections due to methicillin-resistant Staphylococcus aureus (MRSA) and other Gram-positive bacteria are associated with high levels of mortality, morbidity and significant social and economic costs in the U.K. and elsewhere. As the evolution of multi-drug resistance relentlessly erodes the utility of currently available antibacterial drugs, it is essential to maintain efforts to search for new classes of antibacterial agents. Benzimidazoles are potent antihelmintic agents discovered in 1961. Chemical modifications led to the synthesis of the head-to-tail flu
APA, Harvard, Vancouver, ISO, and other styles
10

Lam, Chi-wah. "Antibacterial effects of nanoparticles on cariogenic organisms /." View the Table of Contents & Abstract, 2005. http://sunzi.lib.hku.hk/hkuto/record/B31490414.

Full text
APA, Harvard, Vancouver, ISO, and other styles
More sources

Books on the topic "Antibacterial agents"

1

Anderson, Rosaleen J., Paul W. Groundwater, Adam Todd, and Alan J. Worsley. Antibacterial Agents. John Wiley & Sons, Ltd, 2012. http://dx.doi.org/10.1002/9781118325421.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Dax, Scott L. Antibacterial Chemotherapeutic Agents. Springer Netherlands, 1997. http://dx.doi.org/10.1007/978-94-009-0097-4.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Dax, Scott L. Chemotherapeutic antibacterial agents. Chapman & Hall, 1995.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
4

Mascaretti, Oreste A. Bacteria versus Antibacterial Agents. ASM Press, 2003. http://dx.doi.org/10.1128/9781555817794.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

M, Shafer William, ed. Antibacterial peptide protocols. Humana Press, 1997.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
6

Dax, Scott L. Chemotherapeutic antibacterialagents. Chapman & Hall, 1995.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
7

Amyes, Sebastian G. B. Antibacterial chemotherapy: Theory, problems and practice. Oxford University Press, 2010.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
8

-D, Busse W., Zeiler H. J. 1947-, Labischinski H. 1948-, and Metzger Karl-Georg 1929-, eds. Antibacterial therapy: Achievements, problems, and future perspectives. Springer-Verlag, 1997.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
9

Frost & Sullivan., ed. The U.S. market for antibacterial and antiviral agents. Frost & Sullivan, 1991.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
10

United States. Environmental Protection Agency. Office of Pesticide Programs. Special Review and Reregistration Division, ed. Reregistration eligibility document (RED): M-cresol and xylenol, list D, cases 4027 and 4098. Environmental Protection Agency, Office of Pesticide Programs, Special Review and Reregistration Division, 1994.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
More sources

Book chapters on the topic "Antibacterial agents"

1

Souli, Maria, and Helen Giamarellou. "Antibacterial Agents." In European Handbook of Dermatological Treatments. Springer Berlin Heidelberg, 2015. http://dx.doi.org/10.1007/978-3-662-45139-7_131.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Rhee, Douglas J., Kathryn A. Colby, Lucia Sobrin, and Christopher J. Rapuano. "Antibacterial Agents." In Ophthalmologic Drug Guide. Springer New York, 2010. http://dx.doi.org/10.1007/978-1-4419-7621-5_1.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Ōiwa, Ruiko. "Antibacterial Agents." In The Search for Bioactive Compounds from Microorganisms. Springer New York, 1992. http://dx.doi.org/10.1007/978-1-4612-4412-7_1.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Kern, Winfried V. "Antibacterial Agents." In Infections in Hematology. Springer Berlin Heidelberg, 2014. http://dx.doi.org/10.1007/978-3-662-44000-1_14.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Giamarellou, H., and M. Souli. "Antibacterial agents." In European Handbook of Dermatological Treatments. Springer Berlin Heidelberg, 2003. http://dx.doi.org/10.1007/978-3-662-07131-1_121.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Souli, Maria, Garyfalia Poulakou, and Helen Giamarellou. "Antibacterial Agents." In European Handbook of Dermatological Treatments. Springer International Publishing, 2023. http://dx.doi.org/10.1007/978-3-031-15130-9_134.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Lewis, James S., and Karen Bush. "Antibacterial Agents." In Manual of Clinical Microbiology. ASM Press, 2015. http://dx.doi.org/10.1128/9781555817381.ch68.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Axelsen, Paul H. "Antibacterial Agents." In Essentials of Antimicrobial Pharmacology. Humana Press, 2002. https://doi.org/10.1007/978-1-59259-122-0_2.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Dax, Scott L. "Peptidic antibacterial agents." In Antibacterial Chemotherapeutic Agents. Springer Netherlands, 1997. http://dx.doi.org/10.1007/978-94-009-0097-4_8.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Dax, Scott L. "Miscellaneous antibacterial agents." In Antibacterial Chemotherapeutic Agents. Springer Netherlands, 1997. http://dx.doi.org/10.1007/978-94-009-0097-4_9.

Full text
APA, Harvard, Vancouver, ISO, and other styles

Conference papers on the topic "Antibacterial agents"

1

Baczewska, Maria, Arkadiusz Kuś, Katarzyna Gałczyńska, Michał Arabski, Martyna Mazur, and Małgorzata Kujawińska. "Interferometric methods as a novel approach for bacterial biofilm degradation research." In Digital Holography and Three-Dimensional Imaging. Optica Publishing Group, 2024. http://dx.doi.org/10.1364/dh.2024.w4a.27.

Full text
Abstract:
In this work we present an interferometric approach to quantifying the bacterial growth medium diffusion through a bacterial biofilm pretreated with a tested antibacterial agent. The effect of antibacterial agents on Pseudomonas aeruginosa PAO1 mature biofilm was tested by digital holographic microscopy and laser interferometry and compared with biological tests (spectrofluorimetric measurement of bacterial pyocyanin and pyoverdine production). It is shown that multimodal measurement approach provides better determination of bacterial cell eradication and/or degradation of bacterial matrix for
APA, Harvard, Vancouver, ISO, and other styles
2

Song, HongSeok, YoungGeun Kim, Yeseul Sin, YoungHyo Chang, and YongSoo Park. "Development of Antibacterial Coating against Sulfate Reducing Bacteria." In CORROSION 2011. NACE International, 2011. https://doi.org/10.5006/c2011-11225.

Full text
Abstract:
Abstract In a case that coating like heat shrinkable sheet (HSS) or cold tape is detached from buried pipeline surface, cathodic protection current can’t penetrate into the pipeline surface enough to polarize cathodically due to the impervious characteristic of outer backing layer. Microbiologically induced corrosion can develop seriously at the pipeline inside the failed coating under the favorable environment for sulfate reducing bacteria (SRB) proliferation. A series of works have been performed in order to develop the antibacterial coating against SRB. Minimum inhibitory concentration (MIC
APA, Harvard, Vancouver, ISO, and other styles
3

Karyasa, I. Wayan, and Enike Dwi Kusumawati. "Strategy for Developing Medical Inorganic-Organic Hybrid Biomaterials through the Improvement of Sericulture as a Producer of Renewable Active Biological Raw Materials." In 8th International Conference on Advanced Material for Better Future. Trans Tech Publications Ltd, 2025. https://doi.org/10.4028/p-yox7jx.

Full text
Abstract:
The need for biomaterials is increasing as more and more health problems become more and more complex. Progress in the field of medical biomaterials is also accelerating, but the provision of renewable biomaterials continues to be of concern to the world as awareness of sustainable development in the field of chemistry and health. Various strategies in the development of medical biomaterials were studied through a narrative review of the literature. One of them is the strategy of developing inorganic-organic hybrid medical biomaterials through the cultivation of silkworms as producers of renew
APA, Harvard, Vancouver, ISO, and other styles
4

Costerton, J. W., G. G. Geesey, and P. A. Jones. "Bacterial Biofilms in Relation to Internal Corrosion Monitoring and Biocide Strategies." In CORROSION 1987. NACE International, 1987. https://doi.org/10.5006/c1987-87054.

Full text
Abstract:
Abstract This paper is a review of leading research in the field of bacterial corrosion monitoring with specific emphasis on systems that transport liquids rather than gases. However, the principles of bacterial corrosion presented below are universal and independent of whatever media is transported through the pipeline. It has now been established that the primary mechanism of bacterial corrosion of metal surfaces involves the creation, within an adherent biofilm, of local physiochemical "corrosion cells". The practical consequence of this perception is that we now know that bacteria must be
APA, Harvard, Vancouver, ISO, and other styles
5

Tanji, Y., S. Takano, K. Miyanaga, K. Hori, and H. Unno. "Antibacterial Activity of a Biocide (5-Chloro-2-Methyl-4-Isothiazolin-3-One; CMI) in Biofilm." In CORROSION 2004. NACE International, 2004. https://doi.org/10.5006/c2004-04577.

Full text
Abstract:
Abstract Since 5-chloro-2-methyl-4-isothiazolin-3-one (CMI) has a relatively wide antibacterial spectrum, and low toxicity to humans, it is widely used as a bactericide and fungicide, or a slime control agent for a cooling tower. The minimum inhibitory concentration of CMI for E. coli K-12 was 1.6 mg/l. Short-time (~45 min) exposure of E. coli K-12 to 20 mg/l CMI prolonged the lag phase of cell growth. On the other hand, a normal logarithmic growth phase was observed after the lag phase. When E. coli K-12 was exposed to 1.0 mg/1 CMI for 25 h, the sterilization fraction reached 99%. A CMI conce
APA, Harvard, Vancouver, ISO, and other styles
6

Gutierrez, Margarita, Yorley Duarte, Barbara Arevalo, et al. "NITROGEN HETEROCYCLES AS POTENTIAL ANTIBACTERIAL AGENTS." In The 17th International Electronic Conference on Synthetic Organic Chemistry. MDPI, 2013. http://dx.doi.org/10.3390/ecsoc-17-a035.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Dhilna, C. R., S. M. Gopinath, A. M. Sajith, B. Savitha, S. D. Shruthi, and Muthipeedika Nibin Joy. "Some imidazolyl benzamides as potent antibacterial agents." In PROCEEDINGS OF INTERNATIONAL CONFERENCE ON RECENT TRENDS IN MECHANICAL AND MATERIALS ENGINEERING: ICRTMME 2019. AIP Publishing, 2020. http://dx.doi.org/10.1063/5.0018039.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Radeef, Asmaa, Ahmed Obed, Ansam Yahya, Weaam Abbas, and Amal Matrood. "Increased Resistance of Pseudomonas Aeruginosa and Streptococcus species against Selective Antimicrobial Agents within two Years Interval." In 5th International Conference on Biomedical and Health Sciences. Cihan University-Erbil, 2024. http://dx.doi.org/10.24086/biohs2024/paper.1342.

Full text
Abstract:
Background: Antimicrobial resistance is the phenomenon where a medication loses its efficacy in inhibiting bacterial growth. Bacteria develop resistance and proliferate in the presence of therapeutic concentrations of antibiotics. Bacteria that continue to reproduce in the presence of antibiotics are referred to as resistant bacteria. The occurrence of antibiotic resistance was noted quickly following the introduction of novel antibacterial agents. Antibiotic resistance can arise by natural selection, when bacteria are endowed by nature with varying degrees of inherent low-level resistance. Ai
APA, Harvard, Vancouver, ISO, and other styles
9

Mirolyubova, Tatyana V., Lyudmila V. Redina, and Igor A. Chmutin. "Obtaining and investigating the effectiveness of masterbatches with various antibacterial agents." In INTERNATIONAL SCIENTIFIC-TECHNICAL SYMPOSIUM (ISTS) «IMPROVING ENERGY AND RESOURCE-EFFICIENT AND ENVIRONMENTAL SAFETY OF PROCESSES AND DEVICES IN CHEMICAL AND RELATED INDUSTRIES». The Kosygin State University of Russia, 2021. http://dx.doi.org/10.37816/eeste-2021-2-222-224.

Full text
Abstract:
Some features of obtaining masterbatches with antibacterial agents for the production of polypropylene non-woven spunbond material used for medical masks and dressing gowns are considered, and the results of an experimental study of the effectiveness of the obtained masterbatches for antibacterial activity in laboratory conditions are presented.
APA, Harvard, Vancouver, ISO, and other styles
10

Hashmi, Kulsum, Satya, Priya Mishra, Ekhlakh Veg, Tahmeena Khan, and Seema Joshi. "The Potentiality of Vanadium Complexes as Antibacterial Agents." In ASEC 2024. MDPI, 2025. https://doi.org/10.3390/engproc2025087091.

Full text
APA, Harvard, Vancouver, ISO, and other styles

Reports on the topic "Antibacterial agents"

1

Heijkenskjöld, Lolo. Articles treated with antibacterial agents. Nordic Council of Ministers, 2014. http://dx.doi.org/10.6027/tn2014-513.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Pang, Yuan-Ping. Novel Small-Molecule Antibacterial Agents. Defense Technical Information Center, 2014. http://dx.doi.org/10.21236/ada612221.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Ramnaraine, Daveena. Beyond Antibiotics: Exploring the Antibacterial Mechanisms and Efficacy of Medicinal Plants and Endophytic Fungi. Florida International University, 2025. https://doi.org/10.25148/fiuurj.3.1.14.

Full text
Abstract:
Due to the overuse of antibiotics, antibiotic resistance has become a global health crisis, and has forced an exploration of alternative antibacterial agents. This review explores natural solutions through the antibacterial potential of medicinal plants and their symbiotic endophytic fungi. Medicinal plants have been utilized for centuries to treat infections because of their rich phytochemical content, including alkaloids, flavonoids, and saponins, which exhibit antibacterial properties. Their efficacy is measured through minimum inhibitory concentration (MIC) assays, which showcase their abi
APA, Harvard, Vancouver, ISO, and other styles
4

Cabrera, Anahi Maldonado, Blayra Maldonado Cabrera, Dalia Isabel Sánchez Machado, and Jaime López Cervantes. Wound healing therapeutic effect of chitosan nanofibers: a systematic review and meta- analysis of animal studies. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, 2022. http://dx.doi.org/10.37766/inplasy2022.10.0121.

Full text
Abstract:
Review question / Objective: Review question: Does chitosan base nanofibers has significant wound healing therapeutics effects in animal models? A preclinical systematic review of intervention will be carried out to evaluate the therapeutic effects of chitosan nanofibers on animal skin lesions. The PICO (Population, Intervention, Comparator, Outcome) scheme will be used: Intervention: full-thickness skin lesions, and the application of chitosan nanofibers as treatment for animal skin lesions. Regardless of the concentration of chitosan or other added compounds used. Comparison: No intervention
APA, Harvard, Vancouver, ISO, and other styles
5

Choudhary, Ruplal, Victor Rodov, Punit Kohli, John D. Haddock, and Samir Droby. Antimicrobial and antioxidant functionalized nanoparticles for enhancing food safety and quality: proof of concept. United States Department of Agriculture, 2012. http://dx.doi.org/10.32747/2012.7597912.bard.

Full text
Abstract:
General concept. The reported 1-year study tested the feasibility ofpreparing antimicrobial and antioxidant nanoparticlesfunctionalized with natural phenolic compounds, as a first step to reach the ultimate goal - improving safely and quality of foods by developing novel antimicrobial and antioxidant food-contacting materials. The secondary objectives of the study were (a) selecting the most promising phenoliccompounds, (b) building nanoparticles with the selected phenolicgrafted on their Surface, and (c) testing antimicrobial and antioxidant properties of these particles. The study was expect
APA, Harvard, Vancouver, ISO, and other styles
6

Ficht, Thomas, Gary Splitter, Menachem Banai, and Menachem Davidson. Characterization of B. Melinensis REV 1 Attenuated Mutants. United States Department of Agriculture, 2000. http://dx.doi.org/10.32747/2000.7580667.bard.

Full text
Abstract:
Brucella Mutagenesis (TAMU) The working hypothesis for this study was that survival of Brucella vaccines was directly related to their persistence in the host. This premise is based on previously published work detailing the survival of the currently employed vaccine strains S19 and Rev 1. The approach employed signature-tagged mutagenesis to construct mutants interrupted in individual genes, and the mouse model to identify mutants with attenuated virulence/survival. Intracellular survival in macrophages is the key to both reproductive disease in ruminants and reticuloendothelial disease obser
APA, Harvard, Vancouver, ISO, and other styles
We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!